CTF1 and metabolic dysfunction-associated steatotic liver disease: On the other hand, a previous study enrolled 20 study subjects to investigate the levels of CT-1 in the liver of subjects with NAFLD, and they found that the hepatic CT-1 mRNA expressions were increased in subjects with NAFLD without adjustment for any possible confounding factors [25].